Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 35,696Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Rampex Labs

02 1Allchem Lifescience

03 1Baoding Biochem Technology

04 5Guangdong Raffles PharmaTech Co Ltd

05 3Hangzhou Longshine Bio-Tech Co.,LTD

06 3Haohong (Qihe) Pharmaceutical Technology

07 4Jinan Tantu Chemicals

08 3Shenzhen HwaGen Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

CAS Number : 1195768-20-7

End Use API : Dabrafenib Mesylate

About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...

Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

CAS Number : 1195768-19-4

End Use API : Dabrafenib Mesylate

About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...

Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

CAS Number : 13036-57-2

End Use API : Dabrafenib Mesylate

About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...

Company Banner

04

Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed
arrow

CAS Number : 60230-36-6

End Use API : Dabrafenib Mesylate

About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...

blank

05

Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed
arrow

CAS Number : 630-22-8

End Use API : Dabrafenib Mesylate

About The Company : BDBiochem Technology is an innovative life science partner specializing in high-quality custom chemical and biochemical solutions for the pharmaceutical, biotec...

blank

06

Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed
arrow

CAS Number : 1195768-23-0

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

07

Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed
arrow

CAS Number : 1195768-20-7

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

08

Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed
arrow

CAS Number : 1195768-19-4

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

09

Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed
arrow

CAS Number : 1195768-18-3

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

10

Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed
arrow

CAS Number : 630-22-8

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank